The Oxford American Handbook of Oncology is the essential reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Chapters focus on the immediate information needs in clinical decision making including treatment choices. Algorithms, best practice guidelines, highlighted tables, and targeted lists of landmark references enhance the concise text. For the second edition biologictherapies and therapeutic regimens and options and clinical trial information have been rigorously updated throughout.
Part 1 Background; 1 Molecular cancer biology; 2 Etiology and epidemiology; Part 2 Cancer prevention and screening; 3 Cancer prevention; 4 Cancer screening; 5 Genetic screening; Part 3 Principles of management; 6 Principles of cancer treatment; 7 Surgical oncology; 8 Principles of radiation oncology; 9 Principles of chemotherapy; 10 Hematopoietic stem cell transplantation; 11 Hormone therapy; 12 Targeted therapies; 13 Gene therapy and immunotherapy for cancer; 14 Complementary and alternative medicine; 15 Clinical trials; Part 4 Complications and supportive care; 16 Anemia and fatigue; 17 Febrile neutropenia; 18 Pain management; 19 Venous thromboembolism; 20 Metabolic emergencies; 21 Paraneoplastic syndromes; 22 Superior vena cava syndrome and raised intracranial pressure; 23 Spinal cord compression; 24 Other obstructive complications; 25 Late effects of cancer treatment; 26 End-of-life care; Part 5 Specific cancers; 27 Thoracic cancers; 28 Breast cancer; 29 Gastrointestinal cancer I: esophagus, stomach, small intestine, carcinoid; 30 Gastrointestinal cancer II: pancreas, biliary tract, hepatocellular; 31 Gastrointestinal cancer III: colorectal, anus; 32 Endocrine cancers; 33 Genitourinary cancer I: renal, bladder, ureter, penile carcinomas; 34 Genitourinary cancer II: prostate cancer; 35 Genitourinary cancer III: testicular cancer; 36 Gynecological cancer; 37 Tumors of the central nervous system; 38 Head and neck cancers; 39 Cutaneous malignancies; 40 Soft tissue and bone sarcomas; 41 Acute leukemia; 42 Chronic leukemias and myelodysplastic syndromes; 43 Multiple myeloma; 44 Malignant lymphoma; 45 Cancer of unknown primary (CUP); Appendix;
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.